Introduction: Surgery in patients with head and neck cancers is frequently complicated by multiple stages of procedure that includes significant surgical removal of all or part of an organ with cancer, tissue reconstruction, and extensive neck dissection. Postoperative wound infections, termed 'surgical site infections' are a significant impediment to head and neck cancer surgery and recovery, and need to be addressed. Areas Covered: Up to 10-45% of patients undergoing head-and-neck cancers surgery develop SSIs. SSIs can lead to delayed wound healing, increased morbidity and mortality as well as costs.
need to be considered to reduce future rates, and care is also needed in the selection and duration of antibiotic prophylaxis. Expert commentary: Head and neck surgeons should give personalized care, especially to patients at high risk of SSIs. Such patients include those who have had chemoradiotherapy and need reconstructive surgery, and patients from lower and middle-income countries and from poorer communities in high income countries who often have high levels of co-morbidity because of resource constraints. 1.2 History: SSIs (previously known as 'wound infections') are one of the leading causes of healthcareassociated infections (HCAIs), increasing morbidity, mortality, and healthcare costs through increasing hospital length of stay across advanced as well as lower and middle-income countries (LMICs) [4, 5] .
KEYWORDS
Before the mid-19th Century, most surgical patients developed an SSI which typically started with a pusfilled discharge from the incisional wound leading to sepsis and death [6] . In the late 1860s, Doctor Lister first introduced the principles of antisepsis which, along with other preventive measures over the last 150 years, have resulted in an appreciable reduction in postoperative infections and decreased morbidity and mortality [6] [7] [8] . However, SSIs are still a major healthcare challenge and are associated with poorer patient outcomes [9].
Prevalence of SSIs and Sequelae:
Despite advances in infection prevention and patient safety, SSIs are still one of the most common adverse events that can occur after surgical procedures in all contexts [2, 10, 11] . Bacterial infections in surgical sites leading to SSIs are categorized as incisional or organ/space infections. This differentiates those that occur at incision sites from those associated with organs or spaces handled during operation [12] . SSIs appear particularly problematic and common in LMICs versus high-income countries [13, 14] , for example, there is a pooled incidence rate of 14.8% in Africa with SSIs being a leading cause of infections in hospitals because of resource constraints [11, 15] .
Even in rich nations such as the US, on study reported that SSIs account for 17% of all HCAIs among hospitalized patients [16] and another recent study found that SSIs are found in between 20-31% of HCAIs in hospitalized patients with a death rate of 3%, prolonged hospitalization, increased readmission rates, reoperation, and costs ranging up to US$34,000 per episode [9, 17] . It is hard to determine the actual figure of SSIs in many countries around the world, and although SSIs are a leading cause of hospital acquired infections in high income countries, the poorer infrastructure (such as data record keeping) and other resource constraints in LMICs means that many SSIs go unrecorded and patients needlessly suffer. In 2012, the annual costs of SSIs in the US were estimated at US$3billion per year and rising [5, 18] . In the US, HCAIs, especially SSIs, are viewed seriously, with the government identifying the prevention of SSIs a top national priority [19] . Similar findings are seen in Europe with 19.6% of all HCAIs being SSIs in 2011-2012 [19, 20] . Overall, SSIs can lead to a doubling of the length of hospital stay and a high number of readmissions [21-23].
SSIs related to Head-and-Neck Cancer Surgery Prevalence and Its Consequences: Globally, the
Head-and-Neck cancer prevalence rate is increasing [24] [25] [26] [27] and HNCs continue to remain a substantial public health liability, accounting for more than 550,000 cases and 380, 000 deaths across the world every year [28] . Among such cancers, head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide, with around 600,000 newly diagnosed cases identified each year, and it is the eighth most common cause of cancer mortality [29] [30] [31] . The appreciable rise in HNCs over the last decade has been greatly influenced by a significant rise in rates in LMICs [32, 33], for example HNCs account for 30% of all cancers in India [33] . Surgery has been considered as the predominant and preferred treatment for HNCS since the introduction of the radical en bloc neck dissections in 1905 [29] [30] [31] . Over the last century more refined and safer procedures for HNCS have been introduced, decreasing morbidity and increasing survival [34] [35] [36] [37] . However, despite improvements in aseptic surgical procedures with coverage of antimicrobial prophylaxis, SSIs remain high [38] . SSIs are particularly prevalent with patients undergoing surgery for head-and-neck cancer (HNCS), with between 10-38% developing SSIs [3]. This is a concern, as SSIs related to HNCS can cause major complications leading to increased morbidity and a poorer quality of life due to delayed wound healing and the increasing possibility of delayed postoperative chemoradiotherapy [39] . Although HNCS does not involve the pleural space or accessory respiratory muscles, an appreciable number of patients (up to 44.8%) develop lung and respiratory complications. This rate of complications is much higher than seen in the chest and abdominal surgeries and needs to be carefully monitored [40] [41] [42] [43] [44] .
Consequently, there is a need to review key issues relating to a limiting SSIs following head and neck cancer surgery to reduce future morbidity, mortality, and costs. This is particularly important in LMICs given rising rates of HNCs coupled with high rates of SSIs. HCAIs remain a considerable issue for healthcare systems because of their complexities and complicated nature and under-reporting of infection rates by many hospitals [45] [46] [47] . Overall, SSIs are the second most frequently occurring postoperative HCAIs complication, head and neck surgery (HNS) being no exception [45] . There are also concerns with the length of prophylaxis required to prevent SSIs in LMICs due to issues such as hygiene on the wards [14, [48] [49] [50] . In many LMICs, third-generation cephalosporins (such as ceftriaxone) are widely-used as a prophylaxis to prevent SSIs, which can contribute to increasing antibiotic resistance rates [14, 48, [51] [52] .
These issues need to be reviewed and addressed to improve the care of patients undergoing HNS.
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SURGICAL SITE INFECTIONS OF THE HEAD AND NECK
A multicenter US study found that 15% of patients develop SSIs after microvascular reconstruction surgery for HNCS, with a median time to acquiring an SSI of 11.5 days [53] . In another study of head and neck free flap surgery, 13.84% of patients (67 out of 484) developed SSIs: 33.33% after 1 week, 33.33% after 2 weeks and 45% between 15-30 days post-surgery. 45% of patients developed SSIs after hospital discharge [54] . In a further study regarding squamous cell carcinoma (SCC) and HNS, there was an overall rate of SSIs of 45% (117/260) [55] . As mentioned, HNCs are an increasing concern in LMICs where often there are concerns with resources, not only in personnel but also available medicines [56] .
Consequently, it is imperative in these countries to keep SSIs to a minimum.
HNC refers to malignancy in the anatomical area below the skull base and above the clavicles. A wide range of malignancies are found in the head and neck, including carcinoma, sarcoma, lymphoma and salivary gland tumors [57] . Over 90% of HNCs are SCCs that ascend from the mucosal surfaces of the oral cavity, oropharynx, and larynx [61]. HNSCC is most commonly observed in patients aged over 45 years [58] , with the incidence of the oropharynx and oral cavity carcinoma increasing recently in the 18-45- 
RISK FACTORS FOR SURGICAL SITE INFECTIONS
A South Korean study using univariate analysis identified that pre-operative risk factors associated with SSIs were associated with the location of the tumor; the stage of the tumor; smoking; alcohol habits; low preoperative albumin levels; advanced age; increased body-mass-index; previous radiotherapy; significant blood loss during surgery and smoking also increased SSI rates [36] . A recent Japanese study using univariate analysis found a statistically significant correlation between postoperative SSIs and diabetes (p=0.033), preoperative serum albumin level (p=0.009), and duration of operation (p=0.0093)
[72]. Furthermore, preoperative serum albumin level (<4.0 g/dL) and operation time (≥120 minutes) were found to be independent factors affecting postoperative complications (OR 3.82, p=0.0074; OR 2.83, p=0.0086, respectively) [72].
In another study, discriminant analysis and multiple logistic regression methods identified pre-surgical tracheostomy (p<0.001), previous surgery (p=0.001) and length of pre-operative hospital stay (p<0.001) as the most significant risk factors for SSIs [77] . Surgery included partial mandible resection, the floor of the mouth resection, total larynx resection, and partial tongue resection [77] . A second South Korean retrospective study revealed that male sex (OR 4.281; p=0.004), cardiovascular diseases (OR, 1.941; p=0.020), massive hemorrhage during surgery (OR, 4.213; p=0.001), and surgery lasting longer than 6 hours (OR, 4.213; p=0.002) were statistically significantly linked with SSIs [78].
BACTERIOLOGICAL PROFILE OF SURGICAL SITE INFECTIONS
As mentioned, HNCS can involve difficult procedures involving several stages of major surgical tasks, vascularized tissue rebuilding, and restoration. These operations frequently damage the mucosal lining of the upper respiratory and digestive tract, which necessitates a clean surgical field and reconstruction of the mucosal lining. Because of the disruption to the patency of mucous membranes, SSIs are a serious complication of HNCS, and can lead to delayed wound healing; wound dehiscence; fistula formation, and compromised tissue reconstruction [36]. One study conducted in a rural hospital in a LMIC reported that 17.8% (137 of 768) of patients undergoing HNS had SSIs, and among these patients, 96.4% yielded bacterial growth. Staphylococcus aureus (50.4%) was the commonest pathogen followed by Escherichia coli (23.02%), Pseudomonas aeruginosa (7.9%) and Citrobacter species (7.9%) [79] [65].
Identified pathogens were in 59% of SSIs in a recent multicenter US study with MRSA (6%) and Consequently, prescribing clindamycin alone is considered a significant risk factor for developing SSIs. This is perhaps not surprising in view of clindamycin's bacteriostatic mechanism and limited coverage against GN organisms [36] . Another study researching clindamycin use identified that it was associated with a four times higher chance of SSIs [OR 3.784; 95% CL: 1.367-10.470 (p=0.0100)] after regulating for possibly confounding aspects relating to head and neck free-tissue transfer surgery [80] .
An Indian study also found that out of 46% (488 out of1058) of samples of SSIs, the major pathogens were GN bacilli followed by GP cocci [ . It is important therefore to understand the bacteriological profile of SSIs to improve future preventative strategies.
ROLE OF PROPHYLAXIS OF ANTIMICROBIALS
As noted earlier, many surgical procedures in the head and neck breaches of mucosa lining causing 
METHODS TO REDUCE SURGICAL SITE INFECTIONS
Multiple prevention strategies need to be deployed to prevent SSIs. These include careful meticulous operative procedures, the prudent selection of prophylactic antimicrobials and timely administration [2, 4], and a variety of procedures aimed to offset the threat of bacterial, viral, and fungal contamination posed by operative staff, the operating room environment, and the patient's endogenous skin flora [83] .
Microorganisms normally colonize on the skin surface and exposed tissues, and when the skin is incised, they can multiply and lead to SSIs. Consequently, any procedures that reduce the number of microbes on the skin near the surgical wound will lower the threat of SSIs. The bacterial flora on the skin includes fleeting microbes that are acquired through contact and resident flora that can be removed by washing shown to increase SSI rates [103] [104] [105] [106] [107] [108] . This has led to surgical teams removing hair with clippers and not razors and just before surgery and not the previous evening [6, 117, 118] . It is thought that the microscopic cuts and abrasions resulting from shaving disrupt the skin's natural protective mechanism against microorganism colonization and that the appropriate use of clippers does not damage the patient's skin, which retains its natural protective defense mechanism and help prevent SSIs Overall SSIs are the most frequently occurring HCAIs, increasing both morbidity, mortality, and increasing healthcare cost especially in LMICs as well as significant liability in high income countries. It has been reported that SSIs are often preventable, but the nature of these infections is highly multifarious and requires the incorporation of multiple efforts throughout the perioperative period. In this regard, the World Health Organization (WHO) has developed wide-ranging guidelines that can be utilized internationally [129, 130] . The Center for Disease Control and Prevention (CDC) has also developed very comprehensive guidelines to increase patient benefit and safeguard human life [131] to guide future care.
ANTIMICROBIAL RESISTANCE in SURGICAL SITE INFECTIONS
Evaluation of resistance patterns is key to selecting the most appropriate antibiotic in the hospital to prevent SSIs [36] . In addition to earlier findings (Section 2.2), one recent study conducted in Romania revealed that the most predominant microbial species identified were Staphylococcus aureus (50.72%), [115]. Consequently, it is imperative that the chosen antibiotic(s) for prophylaxis is selected based on local resistance patterns as well as cost issues [13, 51] .
CONCLUSIONS
In general, whilst no statistically significant difference exists between the five-year survival rate of patients with SSIs and without SSIs after HNCS, several other factors need to be considered to help reduce SSIs as they cause stress and discomfort to patients and prolong hospital stay. These factors include the patients' previous history of chemoradiotherapy; advanced stages of carcinoma; smokers; patients with other comorbidities, and those requiring reconstructive surgery [135, 136] . Additionally, clipping is preferable to shaving, and otolaryngology surgeons need to select appropriate antimicrobials for perioperative prophylaxis [36] . Finally, more research is needed to reduce SSIs in patients with HNCS to identify invading pathogens, select appropriate antimicrobials and develop safer surgical procedures to reduce morbidity and increase survival rate. In addition, the extent of the use of excessive postoperative antibiotics should be decreased (especially in LMICs) to reduce future resistance development.
EXPERT COMMENTARY
Globally the HNCS prevalence rate is increasing, and still surgery is the treatment of choice [24] [25] [26] [27] .
HNSCC is the fifth most common cancer worldwide, with around 600,000 newly diagnosed cases added per year, and has the eighth common cause cancer-related mortality [29] [30] [31] Antimicrobial prophylaxis should, therefore, be avoided where possible [39, 83, 89] . Multiple studies report that the SSI rate was high despite routine POPAB for inpatients having surgery for HNCS [90] [91] [92] , however POPAB has now become standard practice [85] . Multiple regimens of POPAB have been developed against SSIs of HNCS [92]. A more recent study using multifactorial analysis found a statistically significantly less probability of developing SSI in patients with HNCS and surgery [93] . A systematic review and meta-analysis found that that patients receiving free flap reconstruction who had antimicrobials for more than 24 hours had more SSI than those receiving them for less 24 hours [94] .
Another study failed to find any statistically significant differences between four different antimicrobial 
FIVE-YEAR VIEW
SSIs remain a major clinical problem in terms of morbidity, mortality, length of hospital stay and overall direct and not-direct costs in all regions of the world. Both the WHO and the CDC have recently published guidelines for the prevention of SSIs. However, despite clear evidence and guidelines to direct SSIs, knowledge, attitude, and awareness of infection prevention and control (IPC) measures among surgeons are often inadequate. Raising the awareness of IPC measures to stakeholders is a crucial factor in changing behaviors. We hope that in the next few years there will be a greater awareness of this problem.
KEY ISSUES
 Head and Neck cancers are increasing in lower and middle-income countries, largely due to increased tobacco and alcohol consumption  Surgical site infections (SSIs) are a common postoperative complication of head and neck surgery  SSIs cause distress to patients, longer hospital stays and higher healthcare costs, delayed recovery and increased morbidity  A number of risk factors need to be addressed which contribute towards increased SSIs, including co-morbidities, increased age, and previous chemoradiotherapy  Pre-operative and postoperative antimicrobials can help reduce infection but must be selected and used appropriately in line with current research evidence on their effectiveness and duration to help reduce resistance
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